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Abstract
Background: The fetal anomaly ultrasound only detects 65 to 81 % of the patients with congenital heart disease,
making it the most common structural fetal anomaly of which a significant part is missed during prenatal life.
Therefore, we need a reliable non-invasive diagnostic method which improves the predictive value for congenital
heart diseases early in pregnancy. Fetal electrocardiography could be this desired diagnostic method. There are
multiple technical challenges to overcome in the conduction of the fetal electrocardiogram. In addition,
interpretation is difficult due to the organisation of the fetal circulation in utero. We want to establish the normal
ranges and values of the fetal electrocardiogram parameters in healthy fetuses of 18 to 24 weeks of gestation.
Methods/Design: Women with an uneventful singleton pregnancy between 18 and 24 weeks of gestation are
asked to participate in this prospective cohort study. A certified and experienced sonographist performs the fetal
anomaly scan. Subsequently, a fetal electrocardiogram recording is performed using dedicated signal processing
methods. Measurements are performed at two institutes. We will include 300 participants to determine the normal
values and 95 % confidence intervals of the fetal electrocardiogram parameters in a healthy fetus. We will evaluate
the fetal heart rate, segment intervals, normalised amplitude and the fetal heart axis. Three months postpartum, we
will evaluate if a newborn is healthy through a questionnaire.
Discussion: Fetal electrocardiography could be a promising tool in the screening program for congenital heart
diseases. The electrocardiogram is a depiction of the intimate relationship between the cardiac nerve conduction
pathways and the structural morphology of the fetal heart, and therefore particularly suitable for the detection of
secondary effects due to a congenital heart disease (hypotrophy, hypertrophy and conduction interruption).
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Background
During pregnancy, the condition of the fetus is assessed
with different techniques. One of these techniques is
ultrasound examination. Between week 18 and 22 of
gestation the fetal anomaly ultrasound is performed.
During this examination, the fetus is screened for all kind
of possible congenital anomalies, including congenital
heart disease (CHD). CHD is defined as a “gross structural
abnormality of the heart or intra-thoracic large vessels,
(possibly) with functional significance” [1]. CHD is the most
common severe congenital anomaly worldwide [2], the
incidence is estimated at 6–12 per 1000 live births [3–5].
CHD is six times more common than chromosomal
anomalies and four times more common than neural tube
defects [4, 6].
The fetal anomaly ultrasound, including planes of the
ventricular outflow tracts and the three-vessel view, only
detects 65 to 81 % of the patients with CHD [6–9]. That
makes CHD the most common structural fetal abnormality
of which a significant part is missed during prenatal life.
Therefore, we need a reliable non-invasive diagnostic
method which improves the predictive value for the
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diagnosis CHD. This diagnostic technique should be able
to diagnose CHD early in pregnancy for multiple reasons.
First, we get the opportunity to identify associated extracar-
diac and chromosomal anomalies that affect fetal and
postnatal prognosis. Second, parents get the chance to opt
for termination of pregnancy in case of a severe CHD.
Third, one can develop an adequate treatment plan includ-
ing intra-uterine therapy, timing, mode and location of
delivery and planning of immediate treatment after birth.
In ductus- and foramen ovale dependent CHDs, it is dem-
onstrated that prenatal diagnosis increases the survival rates
and decreases long term morbidity [10–13].
The currently used two-dimensional ultrasonography
provides multiple anatomic planes, relying on the
sonographists mental reconstruction of these planes to
define the fetal cardiac anatomy. The antenatal diagnos-
tic value is therefore to a great extent depending on the
experience of the performer. As stated by Gardiner; “you
only see what you look for and identify what you already
know” [5]. Three- and four-dimensional ultrasonography
gives a more fluid and representative image of the fetal
cardiac structures, and therefore aids in this mental
reconstruction [14]. Spatio-temporal image correlation
(STIC) is a new modality using automated volume
acquisition of the fetal heart with one sweep of the
probe, further facilitating the examination of the fetal
heart. Disadvantages of these ultrasound modalities are
that they are extremely expensive and only applicable in
centres with experienced personnel.
The non-invasive fetal electrocardiogram (ECG) could
be a valuable tool for the detection of CHD early in
pregnancy. In 1906, Cremer and colleagues were the first
to describe fetal ECG extraction through the maternal
abdomen [15] and 80 years later, Pardi and colleagues
were the first to write a review considering fetal ECG
and, amongst others, CHD [16]. Compared to other
techniques for fetal monitoring, the development of the
fetal ECG lagged behind. This is mainly because there
are multiple technical challenges to overcome. First, at a
gestational age of 20 weeks, the fetal heart is about 1/
10th of the size of an adult heart. Due to the low voltage
of the fetal ECG (1/50th of the maternal ECG), there is
a low signal-to-noise ratio. In addition, identifying the
fetal signals is challenging due to masking by the mater-
nal ECG and high background noises caused by the
maternal electromyogram. The amniotic fluid and
maternal tissues that surround the fetus enlarge the
distance to the electrodes, and cause a non-homogenous
tissue conduction that interferes with signal quality. In
addition, the vernix caseosa causes electrical isolation
and further diminishes the signal amplitude [17]. This is
the main cause of the poor signal-to-noise ratio from 30
to 34 weeks of gestation [18, 19]. Second, the fetal ECG
has a complex three-dimensional shape, alternating with
changes in fetal presentation. Following fetal move-
ments, the electrical signal from each electrode changes
frequently. Another challenging factor is the speed of
the fetal heart rate, which is two to three times faster
compared to the adult heart rate [20].
Besides the technical difficulties encountered when
conducting a fetal ECG, it is also challenging to interpret
the fetal ECG. In contrast with postnatal life, the
systemic circulation in the fetus is fed from both the left
and right ventricle in parallel, with equal intraventricular
pressures [21]. The outflow in the right ventricle is
slightly larger compared to the outflow in the left
ventricle, and increases during gestation; 53 % vs 47 % at
20 weeks of gestation, 57 % vs 43 % at 30 weeks of
gestation and 60 % vs 40 % at 38 weeks of gestation [21].
In utero, the O2-rich blood flows from the umbilical vein
to the right atrium. There, the formamen ovale propels a
major part of the O2-rich blood to the left side of the
heart and into the systemic circulation, bypassing the
fetal lungs. In addition, in the second trimester the
ductus arteriosus propels 40 % of the combined cardiac
output. Because of these major differences between the
systemic circulation in utero and postpartum, it is diffi-
cult to predict what a normal fetal ECG looks like. Fur-
thermore, due to this organisation of the fetal circulation
in utero, in case of a CHD one side of the heart can
compensate for an abnormality on the other site, and
fetuses affected by a CHD do not always show signs of
cardiac failure.
However, before we are able to detect CHD with the
fetal ECG, we need to establish the normal range and
values of amplitudes and segment intervals of the fetal
ECG in a healthy fetus.
Methods/Design
Aim
The aim of this study is to establish the normal ranges and
values (mean with 95 % confidence intervals) of fetal ECG
parameters in a healthy fetus of 18 to 24 weeks of gestation.
Study design
We will perform a prospective cohort study. The study
protocol is approved by the medical ethical committee
of the Máxima Medical Centre, Veldhoven, the
Netherlands (NL48535.015.14).
Setting
Measurements are performed at the Máxima Medical
Centre, Veldhoven, the Netherlands and “Diagnostiek
voor U” (DvU), Eindhoven, the Netherlands. The Máxima
Medical Centre is a tertiary care teaching hospital for
obstetrics. DvU is a diagnostic centre which, amongst
others, performs blood tests and ultrasounds. Measure-
ments are performed directly before or after the
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sonographist performed the fetal anomaly scan. The fetal
anomaly ultrasound is performed by a certified and
experienced sonographist.
Participants
Patients with an uneventful pregnancy, carrying a
singleton fetus with a gestational age between 18 and
24 weeks, are included in the study after written in-
formed consent. At the Máxima Medical Centre, this
will be patients who visit the outpatient clinic for an
appointment. At DvU, this will be patients who visit
the centre for their fetal anomaly ultrasound. These
patients are generally seen by a midwife or by a
doctor at the Máxima Medical Centre for their
obstetrical care. Pregnant women must be aged older
than 18 years. If any of the fetuses turn out to have a
form of CHD, they are excluded from the cohort.
Other exclusion criteria are multiple pregnancies,
insufficient understanding of the Dutch language, and
any known fetal congenital anomalies.
Three months postpartum we will evaluate if the
newborn is healthy, which is defined as absence of
CHD, through a questionnaire. If the neonate turns
out to have a CHD, which was missed at the time of
the structural anomaly ultrasound, we will exclude
the patient from the cohort.
Procedures
The fetal ECG is a non-invasive, transabdominal
research method. The pregnant women is lying down in
a semi-recumbent position to prevent aortocaval com-
pression. The fetal ECG is conducted with eight
electrodes on the maternal abdomen, placed in a fixed
configuration (Fig. 1; consent for publication is ob-
tained). Before applying the electrodes on the abdomen,
the skin is cleaned and prepared by scrubbing the
skin areas with abrasive paper to optimise the skin-
electrode impedance. The impedance is measured after
the skin is prepared and before the fetal ECG recording
is started. A ground and reference electrode are placed
near the belly. The six recording electrodes give bipo-
lar signals that, among others signals, contain the fetal
ECG. The placement of the electrodes is chosen in
order to assess the fetal heart with as much accuracy as
possible. With the fetus able to move freely in the
uterus, at least some of the six electrodes will be close
to the fetal heart and thus will give a usable bipolar sig-
nal. We will record the fetal ECG for 30 min. During
this recording, the fetal position is determined four
times by ultrasound assessment. Good signal quality is
verified via the real-time bedside monitoring system
(Fig. 2).
The fetal ECG signals are digitised and stored by a
prototype fetal ECG system (NEMO Healthcare BV,
the Netherlands). This prototype system comprises of
a 6-channel amplifier that is dedicated for electro-
physiological recordings during pregnancy. After
digitization, the acquired signals are processed by
PC-based dedicated signal processing techniques as
previously described by Vullings et al. [22, 23] to sup-
press interferences such as maternal ECG, powerline,
and electromyographic signals from within the
maternal body, and retrieve the fetal ECG. Following,
we can calculate the fetal ECG for each of the six
electrodes. However, before we can compare ECG
values between patients we need to normalise the
ECG for different orientations of the fetus within the
uterus. A specific electrode would record a different
ECG waveform for a fetus in cephalic position versus
for a fetus in breech position, also yielding differences
in some of the ECG parameters mentioned below.
To normalise for fetal orientation, we calculate the
vectorcardiogram (VCG) of the fetus [24]. This VCG
entails a 3-dimensional representation of the fetal
electrical cardiac activity. As described by Frank et al.
[25], in adult electrocardiography the VCG can be
used to calculate standardised ECG leads such as
Einthoven 1–3, aVF, aVL, and aVR. By mathematically
rotating the fetal VCG prior to calculating the ECG,
we can create standardised fetal ECG leads. The
amount of rotation required is determined based on a
simultaneously performed ultrasound assessment of
the fetal presentation. Via these mathematical rota-
tions, we are also capable of detecting and correcting
for fetal movements in between the ultrasound assess-
ments, as described previously by Vullings et al. [26].
Fig. 1 Configuration of the electrodes on the maternal abdomen.
The fetal ECG is recorded with eight electrodes on the maternal
abdomen, placed in a fixed configuration. A ground and reference
electrode are placed near the belly. The electrodes are connected to
our fetal ECG system, which is connected to a computer. This
system records six channels of fetal ECG data
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The four ultrasound assessments during the measurements
are used to correct for cumulative errors in this correction
method and to determine the initial orientation of the fetus.
To enhance the signal quality of the measurements, the
fetal ECG is filtered further (amongst others by averaging
of the ECG waveforms). The detection of segments and in-
tervals is performed semi-automatically. The detection of
fetal ECG complexes is computerised, while marking of the
fetal ECG intervals (P top, QRS complex, T top) is per-
formed manually by two independent researchers following
a protocol that is verified by an experienced paediatric car-
diologist. We will calculate the inter-observer variability be-
tween the two researchers.
Normal heart rhythm is assumed to show variations in
heartbeat intervals smaller than 20 % between consecutive
beats. In case these variations are larger, this is assumed to
be the result of either fetal arrhythmia or erroneous
detection of the heartbeat interval, e.g. because of poor
signal quality. Assessment of erroneous detection is based
on energy of the ECG signal and correlations between
consecutive ECG waveforms. The ECG is a quasi-periodic
signal, meaning that consecutive ECG waveforms have a
similar appearance and similar amplitude/energy. In case of
poor ECG signal quality, the energy of the ECG signals is
expected to differ from the energy during good quality
recordings. Present artefacts or noise cause the energy of
the ECG to increase beyond physiologically plausible
ranges. Likewise, correlations between consecutive ECG
waveforms are reduced in the presence of poor signal
quality.
It has to be noted here, that fetal arrhythmia can also
cause poor correlation between ECG waveforms. Some
arrhythmias are hence expected to be incorrectly classi-
fied as poor signal quality. This misclassification affects
the detection of fetal arrhythmia, but will not have any
impact on other study parameters as these are deter-
mined only during normal rhythm and good signal
quality. The recording must contain a minimum of 200
ECG complexes that were assessed to have good signal
quality and that were corrected for fetal movement [27].
Study parameters
Multiple outcome values are evaluated:
– Fetal heart rate; mean, standard deviation, 95 %
confidence intervals and heart rate arrhythmia
– Segment intervals (PQ, QRS, ST etc.); mean,
standard deviation and 95 % confidence intervals
– Normalised amplitudes (P, QRS, T); mean, standard
deviation and 95 % confidence intervals
Fig. 2 Real-time bedside monitoring system. Good signal quality can be verified via the real-time bedside monitoring system. Below the green
heart in the top panel on the left, the maternal heart rate is depicted. Right next to this, the uterine activity is shown. Below the blue heart on the
right side of the top panel, the fetal heart rate is depicted. The white lines represent the output from the six abdominal electrodes, while the green
line is a computation of the fetal signal, after subtraction of the maternal signal. In the lower panel in the middle, an estimate of the signal quality
is shown. The user interface can be switched to a different screen in which the cardiotocogram is depicted
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– Fetal electrical heart axis
– % of total patients in which the recording contains
the required amount of data to perform the analysis
Heart rate arrhythmia is defined based on heuristic
rules that dictate that during normal rhythm subse-
quent heartbeat intervals cannot differ more than
20 %. Any rhythm not complying with this rule, and
assessed to not be caused by erroneous detection of
heartbeats, e.g. as a result of poor signal quality, is
labelled as a fetal arrhythmia.
Sample size
There are previously published studies (see Discussion for
more details) that describe fetal ECG parameters. How-
ever, these studies use different methods for obtaining the
fetal signal and do not correct for the fetal position in the
uterus. Therefore they are not able to calculate the fetal
electrical heart axis. Moreover, all studies describe another
parameter of the fetal ECG. Statistical experts calculated
that we need a study population of 200 pregnant patients
in order to determine normal values and 95 % confidence
intervals of a healthy fetus [22]. Anticipating on loss to
follow-up and insufficient data quality, we will include 300
patients in the initial cohort.
Statistical analysis
The collected data is analysed through SPSS. With the
collected data, we perform several analyses. We calculate
the normal values and ranges of the fetal heart rate, seg-
ment intervals (PQ, QRS, ST etc.), normalised ampli-
tudes (P, QRS and T) and the fetal heart axis. Initially,
we will calculate the values and ranges for all included
patients as one group (18 to 24 weeks of gestational
age). Thereafter, we will perform a subanalysis for every
group per week of gestational age.
Discussion
Previous studies have been published regarding the
normal values and ranges of the fetal ECG. In their
review, Pardi et al. summarized the normal evolution of
the cardiac cycle during gestation [16]. From the 17th
week of gestation up to term, the duration of the P-wave
increases progressively. This reflects the anatomical
development of the atria during pregnancy. Similar, the
duration of the QRS-complex increases progressively,
parallel with the weight gain of the fetal heart and in
particular with the gain in ventricular mass. In fetal life,
the intraventricular conduction is delayed compared to
adult values, most likely due to anatomical differences of
the ventricular conduction tissue. There is a slight in-
crease in PR-interval during pregnancy, indicating
development of the atrioventricular conduction tissue.
Recently, longitudinal studies followed pregnancies
from 14 to 41 weeks of pregnancy and performed fetal
ECG measurements during different stages of gestation
[18, 23, 24]. In the 1960’s, Larks and colleagues de-
scribed the orientation of the electrical fetal heart axis
[25, 26, 28, 29]. All mentioned studies performed fetal
ECG recordings with different conduction and analysis
techniques. The amount of electrodes on the maternal
abdomen varied from three to sixteen. Average fetal
ECG complexes were generated from segments of 60 s
up to 2.5 min. Analyses were performed manually or by
computerized signal processing programs. These studies
did not take the fetal position in the uterus into account.
In a group around 20 weeks of gestation, the following
mean values were found by Chia and Taylor respectively:
P wave length 43.9 ms, PR interval 102.1/91.7 ms, QRS
duration 47.2/40.7 ms, QT interval 224.0/242.3 ms and T
wave duration 123.8 ms [23, 24]. Larks found a normal
range of the fetal heart axis between +100 and +160°, with
a mean value of +134° in term fetuses during labour [29].
Due to the lack of correcting for the fetal position in
utero, fetuses in breech position showed a negative
electrical heart axis (−180 to 0°) [28]. In fact, due to the
lack of correcting for fetal position, also findings for
fetuses in vertex position were unreliable. In their analysis,
Larks implicitly assumed that every fetus was facing the
frontal plane. In cases where this assumption was incor-
rect, the measured heart axis must have been incorrect as
a consequence. For example, a fetus with an electrical
heart axis at +135° will indeed be measured as +135° when
facing the frontal plane. When this same fetus, still in
vertex position, rotates to face the sagittal plane, the
measured heart axis will be +90°. When opposing the
frontal plane, the measured heart axis will be +45°.
Up to our knowledge our study is the first to calculate
the fetal electrical heart axis, taken the fetal position into
account. A reliable calculation of the electrical heart axis
is important in interpreting the fetal ECG. In addition,
changes in the orientation of the fetal electrical heart
axis might be able to aid in the diagnosis of congenital
heart disease in the future.
The fetal ECG can be used from early gestation, it
is non-invasive, easy to apply and safe to use [18].
One of the big advantages of the fetal ECG is that it
potentially is a non-expensive diagnostic test in the
long term. In addition, it creates the opportunity to
perform measurements anywhere in the world and
transmit the raw ECG data to be evaluated elsewhere.
The equipment is smaller in comparison to ultra-
sound machines. Moreover, the fetal ECG is evaluated
by semi-computerized algorithms, taking away some
of the performer-dependent variability in diagnostic
value. The fetal ECG system takes minimum training
to be applied.
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The fetal ECG could be a promising clinical tool in
the screening program for CHD. It is a depiction of
the intimate relationship between the cardiac nerve
conduction pathways and the structural morphology
of the fetal heart [8, 30]. The fetal ECG is likely to
be particularly suitable for the detection of secondary
effects due to a CHD; hypotrophy, hypertrophy and
conduction interruption.
Abbreviations
CHD, congential heart disease; ECG, electrocardiograhy/electrocardiogram;





Availability of data and material
The datasets generated during and/or analysed during the current study are
not publicly available since this was not mentioned in the patient informed
consent that was signed by the included patients. Requests addressed to the
corresponding author will be discussed with the medical ethical reviewing
committee of the Máxima Medical Centre.
Authors’ contributions
KV participated in the design of the study, will be acquiring the data, will be
involved in the analysis and interpretation of the data, and wrote the
manuscript. CL will be acquiring the data, will be involved in the analysis
and interpretation of the data and wrote the manuscript. RV participated in
the design of the study, will be involved in the analysis and interpretation of
the data and revised the manuscript. CS participated in the design of the
study, will be involved in the interpretation of the data and revised the
manuscript. TD participated in the design of the study, will be involved in
the analysis and interpretation of the data and revised the manuscript. JL
participated in the design of the study, will be involved in the interpretation
of the data and revised the manuscript. SO participated in the design of the
study, will be involved in the interpretation of the data and revised the
manuscript. All authors have read and approved the final manuscript.
Competing interests
RV is shareholder in Nemo Healthcare BV, the Netherlands. The other authors
declare that they have no competing interests.
Consent for publication
Consent for publication is obtained from the person that is displayed in Fig. 1.
Ethics approval and consent to participate
The study protocol is reviewed and approved by the medical ethical
reviewing committee of the Máxima Medical Centre, Veldhoven, the
Netherlands (NL48535.015.14).
Author details
1Department of Obstetrics and Gynaecology, Máxima Medical Centre, P.O.
box 77775500 MB Veldhoven, The Netherlands. 2Faculty of Electrical
Engineering, Eindhoven University of Technology, P.O. box 5135612 AZ
Eindhoven, The Netherlands. 3Department of Paediatrics, Máxima Medical
Centre, P.O. box 77775500 MB Veldhoven, The Netherlands. 4Department of
Biomedical Engineering, CARIM School for Cardiovascular Diseases,
Maastricht University, P.O. Box 6166200 MD Maastricht, The Netherlands.
Received: 16 April 2015 Accepted: 8 August 2016
References
1. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109
births. Incidence and natural history. Circulation. 1971;43(3):323–32.
2. van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA,
Takkenberg JJ, Roos-Hesselink JW. Birth prevalence of congenital heart
disease worldwide: a systematic review and meta-analysis. J Am Coll
Cardiol. 2011;58(21):2241–7.
3. Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS,
Abuhamad A, Cuneo BF, Huhta JC, Jonas RA, Krishnan A, Lacey S, Lee W,
Michelfelder EC S, Rempel GR, Silverman NH, Spray TL, Strasburger JF,
Tworetzky W, Rychik J, American Heart Association Adults With Congenital
Heart Disease Joint Committee of the Council on Cardiovascular Disease in the
Young and Council on Clinical Cardiology, Council on Cardiovascular Surgery
and Anesthesia, Council on Cardiovascular and Stroke Nursing. Diagnosis and
treatment of fetal cardiac disease: a scientific statement from the American
Heart Association. Circulation. 2014;129(21):2183–242.
4. Simpson LL. Screening for congenital heart disease. Obstet Gynecol Clin
North Am. 2004;31(1):51–9.
5. Gardiner HM. Keeping abreast of advances in fetal cardiology. Early Hum
Dev. 2006;82(6):415–9.
6. Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B.
Improving the effectiveness of routine prenatal screening for major
congenital heart defects. Heart. 2002;88(4):387–91.
7. Kirk JS, Riggs TW, Comstock CH, Lee W, Yang SS, Weinhouse E. Prenatal
screening for cardiac anomalies: the value of routine addition of the aortic
root to the four-chamber view. Obstet Gynecol. 1994;84(3):427–31.
8. Ogge G, Gaglioti P, Maccanti S, Faggiano F, Todros T. Prenatal screening for
congenital heart disease with four-chamber and outflow-tract views: a
multicenter study. Ultrasound Obstet Gynecol. 2006;28(6):779–84.
9. Wu Q, Li M, Ju L, Zhang W, Yang X, Yan Y, Wang W. Application of the
3-vessel view in routine prenatal sonographic screening for congenital
heart disease. J Ultrasound Med. 2009;28(10):1319–24.
10. Brick DH, Allan LD. Outcome of prenatally diagnosed congenital heart
disease: an update. Pediatr Cardiol. 2002;23(4):449–53.
11. Hunter LE, Simpson JM. Prenatal screening for structural congenital heart
disease. Nat Rev Cardiol. 2014;11(6):323–34.
12. Brown KL, Ridout DA, Hoskote A, Verhulst L, Ricci M, Bull C. Delayed
diagnosis of congenital heart disease worsens preoperative condition and
outcome of surgery in neonates. Heart. 2006;92(9):1298–302.
13. Trines J, Fruitman D, Zuo KJ, Smallhorn JF, Hornberger LK, Mackie AS.
Effectiveness of prenatal screening for congenital heart disease: assessment in a
jurisdiction with universal access to health care. Can J Cardiol. 2013;29(7):879–85.
14. Rogers L, Li J, Liu L, Balluz R, Rychik J, Ge S. Advances in fetal
echocardiography: early imaging, three/four dimensional imaging, and role
of fetal echocardiography in guiding early postnatal management of
congenital heart disease. Echocardiography. 2013;30(4):428–38.
15. Cremer M. Über die direkte Ableitung der Aktionsströme des menschlichen
Herzens vom Oesophagus und über das Elektrokardiogramm des Fötus.
Münch Med Wschr. 1906;53:811–3.
16. Pardi G, Ferrazzi E, Cetin I, Rampello S, Baselli G, Cerutti S, Civardi S. The
clinical relevance of the abdominal fetal electrocardiogram. J Perinat Med.
1986;14(6):371–7.
17. Kimura Y, Sato N, Sugawara J, Velayo C, Hoshiai T, Nagase S, Ito T, Onuma Y,
Katsumata A, Okamura K, Yaegashi N. Recent advances in fetal
electrocardiography. Open Med Devices J. 2012;4:7–12.
18. van Laar JO, Warmerdam GJ, Verdurmen KM, Vullings R, Peters CH,
Houterman S, Wijn PF, Andriessen P, van Pul C, Guid Oei S. Fetal heart rate
variability during pregnancy, obtained from non-invasive electrocardiogram
recordings. Acta Obstet Gynecol Scand. 2014;93(1):93–101.
19. Oostendorp TF, van Oosterom A, Jongsma HW. The fetal ECG
throughout the second half of gestation. Clin Phys Physiol Meas.
1989;10(2):147–60.
20. Van Mieghem T, DeKoninck P, Steenhaut P, Deprest J. Methods for prenatal
assessment of fetal cardiac function. Prenat Diagn. 2009;29(13):1193–203.
21. Kiserud T, Acharya G. The fetal circulation. Prenat Diagn. 2004;24(13):1049–59.
22. Altman DG. Practical Statistics for Medical Research. London: Chapman&Hall/
CRC; 1990.
23. Chia EL, Ho TF, Rauff M, Yip WC. Cardiac time intervals of normal fetuses using
noninvasive fetal electrocardiography. Prenat Diagn. 2005;25(7):546–52.
24. Taylor MJ, Smith MJ, Thomas M, Green AR, Cheng F, Oseku-Afful S, Wee LY,
Fisk NM, Gardiner HM. Non-invasive fetal electrocardiography in singleton
and multiple pregnancies. BJOG. 2003;110(7):668–78.
25. Larks SD, Larks GG. Components of the fetal electrocardiogram and
intrauterine electrical axis: quantitative data. Biol Neonat. 1966;10(3):140–52.
Verdurmen et al. BMC Pregnancy and Childbirth  (2016) 16:227 Page 6 of 7
26. Larks SD, Larks GG. Comparative aspects of the fetal and newborn
electrocardiograms. Evidence for the validity of the method for calculation of the
electrical axis of the fetal heart. Am J Obstet Gynecol. 1966;96(4):553–5.
27. Vullings R, Mischi M, Oei SG, Bergmans JW. Novel Bayesian
vectorcardiographic loop alignment for improved monitoring of ECG and
fetal movement. IEEE Trans Biomed Eng. 2013;60(6):1580–8.
28. Larks SD. Estimation of the electrical axis of the fetal heart. Am J Obstet
Gynecol. 1965;91:46–55.
29. Larks SD, Larks GG. The electrical axis of the fetal heart: a new criterion for
fetal well-being or distress. Am J Obstet Gynecol. 1965;93(7):975–83.
30. Velayo C, Sato N, Ito T, Chisaka H, Yaegashi N, Okamura K, Kimura Y.
Understanding congenital heart defects through abdominal fetal
electrocardiography: case reports and clinical implications. J Obstet
Gynaecol Res. 2011;37(5):428–35.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Verdurmen et al. BMC Pregnancy and Childbirth  (2016) 16:227 Page 7 of 7
